Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non-profit foundation

Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):838-845. doi: 10.1002/ajmg.c.31825. Epub 2020 Aug 11.

Abstract

The Foundation Fighting Blindness is a 50-year old 501c(3) non-profit organization dedicated to supporting the development of treatments and cures for people affected by the inherited retinal diseases (IRD), a group of clinical diagnoses that include orphan diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease, among others. Over $760 M has been raised and invested in preclinical and clinical research and resources. Key resources include a multi-national clinical consortium, an international patient registry with over 15,700 members that is expanding rapidly, and an open access genetic testing program that provides no cost comprehensive genetic testing to people clinically diagnosed with an IRD living in the United States. These programs are described with particular focus on the challenges and outcomes of establishing the registry and genetic testing program.

Keywords: clinical consortium; inherited retinal diseases; open access genetic testing; patient registry; venture philanthropy.

MeSH terms

  • Access to Information*
  • Adult
  • Female
  • Genetic Testing*
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics
  • Organizations, Nonprofit
  • Registries
  • Retinal Diseases / classification
  • Retinal Diseases / diagnosis*
  • Retinal Diseases / epidemiology
  • Retinal Diseases / genetics*
  • Young Adult